RxDoctor Payments DataLook up a doctor →

Ashley Steinhauer, NP

Nurse Practitioner · Covington, LANPI 1356624555

Payments from drug & device makers

$7,047in general payments, 2019–2025

Across 351 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$673
  • Johnson & Johnson$603
  • Bristol Myers Squibb$521
  • E.r. Squibb & Sons, L.L.C.$409
  • Pfizer$363
  • Merck$326
  • plus $4K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis39$673
Johnson & Johnson(2 entities)25$603
Bristol Myers Squibb29$521
E.r. Squibb & Sons, L.L.C.17$409
Pfizer20$363
Merck16$326
AstraZeneca(2 entities)14$279
Takeda Pharmaceuticals U.S.A., Inc.11$226
AbbVie9$216
Astellas Pharma US Inc9$201
Incyte Corporation10$201
Daiichi Sankyo Inc.7$177
Sanofi-aventis U.S. LLC2$165
Eisai Inc.8$158
Sanofi8$147
AVEO Pharmaceuticals, Inc.6$132
Gilead(2 entities)7$127
Genentech USA, Inc.7$123
Bayer7$121
Exelixis Inc.6$120
GSK6$119
Stemline Therapeutics Inc.6$99
Seagen Inc.5$98
Array Biopharma Inc4$83
Adaptive Biotechnologies Corporation4$82
Regeneron Healthcare Solutions, Inc.3$69
Amgen4$69
Servier Pharmaceuticals LLC3$68
Beigene USA, Inc.3$65
Jazz Pharmaceuticals Inc.3$62
Sobi, Inc3$61
Lilly USA, LLC3$57
Novo Nordisk3$56
Beone Medicines USA, Inc.3$54
Mirati Therapeutics, Inc.3$54
Pharmacosmos Therapeutics Inc.3$53
Ipsen Biopharmaceuticals, Inc2$51
Geron Corporation2$51
Rigel Pharmaceuticals, Inc.2$41
Blueprint Medicines Corporation2$39
Tempus AI, Inc2$37
Veracyte, Inc.3$36
ADC Therapeutics America, Inc.2$33
Genmab U.S., Inc.2$30
Pharmaessentia USA Corporation1$24
Myriad Genetic Laboratories, Inc.1$22
Sun Pharmaceutical Industries Inc.1$22
Cumberland Pharmaceuticals, Inc.1$21
Biohaven Pharmaceuticals, Inc.1$21
Agios Pharmaceuticals, Inc.1$19
Tersera Therapeutics LLC1$19
Tactile Systems Technology Inc1$17
G1 Therapeutics, Inc.1$17
Puma Biotechnology, Inc.1$16
CTI Biopharma Corp.1$14
EMD Serono, Inc.1$14
Spectrum Pharmaceuticals Inc.1$14
Immunogen, Inc.1$14
Karyopharm Therapeutics Inc.1$13
Ferring Pharmaceuticals Inc.1$12

How this compares

$7,047 in reported general payments places this provider in the 90th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Medicare billing

Part B allowed, 2024
$2,587
Medicare patients
17
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →